Related Experiment Videos
In-vivo effects of clindamycin on polymorphonuclear leucocyte phagocytosis and killing of gram-negative organisms
Abstract:
Polymorphonuclear leucocyte (PMNL) phagocytosis and killing were evaluated in ten healthy volunteers who had received 600 mg of clindamycin intramuscularly. Serum obtained 3 h after the administration of clindamycin significantly increased PMNL phagocytosis and killing of Gram-negative aerobic organisms. Serum obtained at 12 and 24 h after the administration of the drug did not induce a significant increase in PMNL phagocytosis and killing. The administration of clindamycin had no direct effect on the PMNLs in terms of their phagocytic and bactericidal function. These results demonstrate serum-associated augmentation of PMNL function by clindamycin in vivo which may be of potential clinical benefit in the outcome of infections.
Insights
Clindamycin boosts immune cell function, enhancing the body's ability to fight infections. This effect, observed in healthy volunteers, shows clindamycin's potential clinical benefits.
Area of Science:
- Pharmacology
- Immunology
- Microbiology
Background:
- Polymorphonuclear leukocytes (PMNLs) are crucial for innate immunity.
- Phagocytosis and killing are key functions of PMNLs in combating bacterial infections.
- Clindamycin is an antibiotic used to treat various infections.
Purpose of the Study:
- To investigate the effect of clindamycin on PMNL phagocytosis and killing.
- To determine if clindamycin directly or indirectly enhances PMNL function.
Main Methods:
- Ten healthy volunteers received 600 mg of clindamycin intramuscularly.
- PMNL function (phagocytosis and killing) was assessed using serum collected at 3, 12, and 24 hours post-administration.
- Assays focused on Gram-negative aerobic organisms.
Main Results:
- Serum from 3 hours post-clindamycin administration significantly enhanced PMNL phagocytosis and killing.
- No significant enhancement of PMNL function was observed with serum collected at 12 and 24 hours.
- Clindamycin did not directly impact PMNL phagocytic or bactericidal capacity.
Conclusions:
- Clindamycin administration in vivo leads to serum-associated augmentation of PMNL function.
- This indirect enhancement of immune cell activity may contribute to the clinical efficacy of clindamycin in treating infections.